Cystic degeneration during neo-adjuvant chemotherapy predicts squamous metaplasia of triple negative breast cancer: report of two cases-Reference-Cited by-同舟云学术

Cystic degeneration during neo-adjuvant chemotherapy predicts squamous metaplasia of triple negative breast cancer: report of two cases

Published:2022-06-17 Issue:4 Volume:11 Page:247-252
ISSN:2192-3183
Container-title:International Cancer Conference Journal
language:en
Short-container-title:Int Canc Conf J

Author:

Inoue Masayuki,Kimura Ayako,Oka Tomomi,Yajima Aya,Higuchi Yudai,Endo Tatsuki,Watanabe Hideki,Nakagomi Hiroshi^ORCID,Oyama Toshio

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://link.springer.com/content/pdf/10.1007/s13691-022-00553-y.pdf

Reference16 articles.

1. Mieog JS, van der Hage JA, van de Velde CJ (2007) Preoperative chemotherapy for women with operable breast cancer. Cochrane Database Syst Rev 2:CD005002

2. Early Breast Cancer Trialists’ Collaborative Group (2018) Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol 19:27–39

3. Kumaki N, Umemura S, Tang X et al (2011) Alteration of immunohistochemical biomarkers between pre- and post-chemotherapy: hormone receptors, HER2 and Ki-67. Breast Cancer 18:98–102

4. Fangberget A, Nilsen LB, Hole KH et al (2010) Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol 21:1188–1199

5. Arlinghaus LR, Li X, Levy M et al (2010) Current and future trends in magnetic resonance imaging assessments of the response of breast tumors to neoadjuvant chemotherapy. J Oncol 2010:919620

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2-Positive Metaplastic Breast Cancer with Resistance to Neoadjuvant Chemotherapy: Case Report;Case Reports in Oncology;2023-11-24

2. Antineoplastics;Reactions Weekly;2023-07-08